Venture Capital

Swiss medtech firm CorFlow is tackling a major post-heart attack complication with two pivotal trials, aiming to create a new standard of care.

TIME recognizes Fora's disruptive platform, which empowers thousands of new entrepreneurs to redefine the travel advisor role with AI-supercharged expertise.

With new funding, DISA Technologies is scaling its unique HPSA™ tech to secure US supply chains and remediate the toxic legacy of abandoned uranium mines.

Former HHS Secretary Tommy Thompson joins Vector Science & Therapeutics, leveraging his political clout to advance a novel transdermal drug delivery platform.

New research reveals food and beverage brands are misallocating ad spend by targeting a non-existent average consumer, ignoring three distinct buyer types.

With double-digit growth and key US acquisitions, ESTEVE is rapidly expanding. But it's the firm's B Corp status that may redefine success in pharma.

The Canadian miner's new OTCQB listing aims to attract American capital, fueling exploration of its promising gold and copper assets in British Columbia.

South Korea approves its first homegrown CAR-T therapy, a landmark achievement offering new hope for lymphoma patients with impressive response rates.

The £87M take-private deal merges VertiGIS's applications with 1Spatial's data expertise, aiming to dominate the AI-driven geospatial solutions market.

With a $1.8M grant, AltaLink is using real-time weather data to unlock hidden capacity in power lines, saving money and boosting grid reliability.

NETGEAR smashed Q1 profit forecasts, driven by its booming enterprise unit. The company's strategic pivot to high-margin products is paying off.

With $5M in new funding and key regulatory validation, Sapho Bio's rapid sterility test promises to slash drug release times and speed medicines to patients.

With a $44M Series A, Guild.ai introduces a new platform to govern autonomous AI agents, aiming to solve the enterprise challenge of security and control.

With its new M1 multi-bay robotic system and $13M in fresh funding, Rocsys is automating the depot to unlock the future of autonomous vehicle fleets.

A new partnership between a sports tech startup and an NFL star's foundation reveals how AI is set to revolutionize training for everyday athletes.

The clinical trial leader renewed a key global certification, signaling a new era of quality and trust that could accelerate breakthroughs in Alzheimer's.

A new venture aims to replace your phone with AR glasses powered by 6G, but can it overcome huge tech hurdles and beat giants like Apple and Meta?

Mayors from eight nations gathered in Xi'an, forging a new consensus on tech, culture, and green growth at the historic Silk Road's starting point.

As AI accelerates drug approvals, a new bottleneck emerges. Firms like Totaligent are betting on the infrastructure needed to get therapies to patients.

Actor Terry Crews and 'Drive to Survive' creators team up for a new series taking fans inside the launch of the Cadillac Formula 1® team.